modelMorphine_Ihmsen2021_reference

Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_3M_9C (Parent and up to two metabolites, each with central + peripheral + peripheral 2 compartments; metabolites formed (one way) from the parent central compartment).

Information

name:morphine
ATC code:N02AA01
model:parent and metabolites, formed from the central compartment (PK_3M_9C)
source:Ihmsen H et al. 2021
population:adults undergoing cardiac surgery
measured compound:morphine
review:curated candidate
record page:pharmacolibrary-docs

Parameters as reported in the paper

parametervalueunitmeaning
CL (L/min)1.35L/minCL
Q₂ (L/min)1.16L/minQ
Q₃ (L/min)1.71L/minQ3
V₁ (L)8.1LV1
V₂ (L)18.4LV2
V₃ (L)165LV3
F_M (morphine-6-glucuronide)0.1fm
K_M (1/min) (morphine-6-glucuronide)0.0371/minkfm
CL_M (L/min) (morphine-6-glucuronide)0.098L/minCL
Q_2M (L/min) (morphine-6-glucuronide)0.068L/minQ
V_1M (L) (morphine-6-glucuronide)5.5LV1
V_2M (L) (morphine-6-glucuronide)10.3LV2

About morphine

Morphine is an opioid painkiller used to treat pain, and also dyspnea and fibromyalgia. It is widely used and appears on the WHO list of essential medicines.

Summary written by glm-5.3-flash from Wikidata Q81225 and the WHO ATC classification; not checked by a person.

Identity, molar mass and metabolites: Morphine.

References

  1. Ihmsen H et al. (2021). Pharmacokinetics of Morphine and Morphine-6-Glucuronide During Postoperative Pain Therapy in Cardiac Surgery Patients. European journal of drug metabolism and pharmacokinetics 46(2):249–263. DOI:10.1007/s13318-020-00663-z PUBMED:33547559

Parameters

TypeNameDefaultDescription
RealmassRatio_m1 (from PK_3M_9C)if MW > 0 and MW_m1 > 0 then MW_m1/MW else 1
RealmassRatio_m2 (from PK_3M_9C)if MW > 0 and MW_m2 > 0 then MW_m2/MW else 1
Pharmacolibrary.Types.MassadminMass (from PK_3M_9C)1e-4oral dose mass (0 = no oral dose; an IV-only model sets 0)
Pharmacolibrary.Types.MassinfusionMass (from PK_3M_9C)0IV / parenteral dose mass into the parent central compartment (0 = no IV dose); bioavailability 1
IntegeradminCount (from PK_3M_9C)1number of doses (-1 = unlimited)
Modelica.Units.SI.TimeadminPeriod (from PK_3M_9C)8*3600period of administration
Modelica.Units.SI.TimeadminDuration (from PK_3M_9C)1oral administration duration (a 1 s bolus into the gut)
Modelica.Units.SI.TimeinfusionDuration (from PK_3M_9C)adminDurationIV infusion duration (default: adminDuration, i.e. a bolus)
Modelica.Units.SI.TimeadminTime (from PK_3M_9C)60first administration time (s); 60 as in PK_1C, not 0 — a co-simulation FMU starting a dose pulse at t = 0 doses one communication step too long
Modelica.Units.SI.MassFractionF (from PK_3M_9C)1bioavailability (0-1)
Pharmacolibrary.Types.TransferRateka (from PK_3M_9C)0.016666666666666666first order absorption rate (oral dosing only)
Modelica.Units.SI.TimeTlag (from PK_3M_9C)0delay between oral administration and absorption (oral dosing only)
Types.VolumeVd1 (from PK_3M_9C)0parent: central volume
Types.VolumeVd2 (from PK_3M_9C)0parent: peripheral volume
Types.VolumeVd3 (from PK_3M_9C)0parent: peripheral 2 volume
Types.VolumeVd1m1 (from PK_3M_9C)0metabolite 1: central volume
Types.VolumeVd2m1 (from PK_3M_9C)0metabolite 1: peripheral volume
Types.VolumeVd3m1 (from PK_3M_9C)0metabolite 1: peripheral 2 volume
Types.VolumeVd1m2 (from PK_3M_9C)0metabolite 2: central volume
Types.VolumeVd2m2 (from PK_3M_9C)0metabolite 2: peripheral volume
Types.VolumeVd3m2 (from PK_3M_9C)0metabolite 2: peripheral 2 volume
Types.Clearanceq12 (from PK_3M_9C)0parent: central -> peripheral (0 = no peripheral)
Types.Clearanceq21 (from PK_3M_9C)0parent: peripheral -> central
Types.Clearanceq13 (from PK_3M_9C)0parent: central -> peripheral 2 (0 = no peripheral 2)
Types.Clearanceq31 (from PK_3M_9C)0parent: peripheral 2 -> central
Types.ClearanceCL1 (from PK_3M_9C)0parent: elimination from central by routes other than M1/M2 formation
Types.Clearanceq1_m11 (from PK_3M_9C)0formation of metabolite 1 from parent central (0 = no metabolite 1)
Types.Clearanceq1_m21 (from PK_3M_9C)0formation of metabolite 2 from parent central (0 = no metabolite 2)
Types.Clearanceqm11_m12 (from PK_3M_9C)0metabolite 1: central -> peripheral
Types.Clearanceqm12_m11 (from PK_3M_9C)0metabolite 1: peripheral -> central
Types.Clearanceqm11_m13 (from PK_3M_9C)0metabolite 1: central -> peripheral 2
Types.Clearanceqm13_m11 (from PK_3M_9C)0metabolite 1: peripheral 2 -> central
Types.ClearanceCLm1 (from PK_3M_9C)0metabolite 1: elimination from central
Types.Clearanceqm21_m22 (from PK_3M_9C)0metabolite 2: central -> peripheral
Types.Clearanceqm22_m21 (from PK_3M_9C)0metabolite 2: peripheral -> central
Types.Clearanceqm21_m23 (from PK_3M_9C)0metabolite 2: central -> peripheral 2
Types.Clearanceqm23_m21 (from PK_3M_9C)0metabolite 2: peripheral 2 -> central
Types.ClearanceCLm2 (from PK_3M_9C)0metabolite 2: elimination from central
Info › Molar masses
Modelica.Units.SI.MolarMassMW (from PK_3M_9C)0parent molar mass [kg/mol]; 0 = not supplied
Modelica.Units.SI.MolarMassMW_m1 (from PK_3M_9C)0metabolite 1 molar mass [kg/mol]; 0 = not supplied
Modelica.Units.SI.MolarMassMW_m2 (from PK_3M_9C)0metabolite 2 molar mass [kg/mol]; 0 = not supplied

Connectors

TypeNameDefaultDescription
Interfaces.ConcentrationPort_bcentralCPort (from PK_3M_9C)parent central compartment
Interfaces.ConcentrationPort_bcentralM1CPort (from PK_3M_9C)metabolite 1 central compartment
Interfaces.ConcentrationPort_bcentralM2CPort (from PK_3M_9C)metabolite 2 central compartment
Types.ConcentrationOutputC_central (from PK_3M_9C)parent concentration, central compartment
Types.ConcentrationOutputC_M1 (from PK_3M_9C)metabolite 1 concentration, central compartment
Types.ConcentrationOutputC_M2 (from PK_3M_9C)metabolite 2 concentration, central compartment

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_3M_9C)
Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_3M_9C)
Pharmacokinetic.NoPerfusedTissueCompartmentperipheral2 (from PK_3M_9C)
Pharmacokinetic.NoPerfusedTissueCompartmentcentral_M1 (from PK_3M_9C)
Pharmacokinetic.NoPerfusedTissueCompartmentperipheral_M1 (from PK_3M_9C)
Pharmacokinetic.NoPerfusedTissueCompartmentperipheral2_M1 (from PK_3M_9C)
Pharmacokinetic.NoPerfusedTissueCompartmentcentral_M2 (from PK_3M_9C)
Pharmacokinetic.NoPerfusedTissueCompartmentperipheral_M2 (from PK_3M_9C)
Pharmacokinetic.NoPerfusedTissueCompartmentperipheral2_M2 (from PK_3M_9C)
Sources.PeriodicDose_EnteralperiodicDose (from PK_3M_9C)
Pharmacokinetic.TransferFirstOrderNonSymQ12 (from PK_3M_9C)
Pharmacokinetic.TransferFirstOrderNonSymQ13 (from PK_3M_9C)
Pharmacokinetic.ClearanceDrivenEliminationCL_1 (from PK_3M_9C)
Pharmacokinetic.TransferMetabolicConversionQf1 (from PK_3M_9C)formation of metabolite 1
Pharmacokinetic.TransferMetabolicConversionQf2 (from PK_3M_9C)formation of metabolite 2
Pharmacokinetic.TransferFirstOrderNonSymQm1_12 (from PK_3M_9C)
Pharmacokinetic.TransferFirstOrderNonSymQm1_13 (from PK_3M_9C)
Pharmacokinetic.ClearanceDrivenEliminationCL_m1 (from PK_3M_9C)
Pharmacokinetic.TransferFirstOrderNonSymQm2_12 (from PK_3M_9C)
Pharmacokinetic.TransferFirstOrderNonSymQm2_13 (from PK_3M_9C)
Pharmacokinetic.ClearanceDrivenEliminationCL_m2 (from PK_3M_9C)
Pharmacolibrary.Sources.PeriodicDoseinfusionDose (from PK_3M_9C)

Revisions

  • 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Ihmsen_2021: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: curated candidate